Literature DB >> 18660702

Activation of the innate immune system by the endogenous ligand hyaluronan.

Anushree C Shirali1, Daniel R Goldstein.   

Abstract

PURPOSE OF REVIEW: Endogenous ligands are released during ischemia-reperfusion injury that occurs during organ transplantation. Evidence suggests that these ligands, such as hyaluronan, activate the innate immune system via Toll-like receptors. This review will highlight the studies on the role of hyaluronan in modulating alloimmune responses. RECENT
FINDINGS: Within the last year, the role of hyaluronan as an endogenous activator of innate alloimmunity has been investigated. We have shown that hyaluronan activates dendritic cells and primes T-cell alloimmunity primarily via a toll like receptor 4/Tirap-dependent pathway. Recent studies have described that the hyaluronan receptor, CD44, modulates these innate immune responses by augmenting regulatory T-cell function, and augmenting the expression of negative regulators of Toll-like receptor signaling.
SUMMARY: Hyaluronan activates innate alloimmune responses and subsequently influences adaptive alloimmunity. Improving our understanding of the nature of endogenous innate ligands that activate alloimmunity may lead to improved therapeutics in organ transplantation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18660702     DOI: 10.1097/MOT.0b013e3282f3df04

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  19 in total

1.  Imaging of homeostatic, neoplastic, and injured tissues by HA-based probes.

Authors:  Mandana Veiseh; Daniel Breadner; Jenny Ma; Natalia Akentieva; Rashmin C Savani; Rene Harrison; David Mikilus; Lisa Collis; Stefan Gustafson; Ting-Yim Lee; James Koropatnick; Leonard G Luyt; Mina J Bissell; Eva A Turley
Journal:  Biomacromolecules       Date:  2011-12-12       Impact factor: 6.988

Review 2.  Inflammation and transplantation tolerance.

Authors:  Daniel R Goldstein
Journal:  Semin Immunopathol       Date:  2011-02-18       Impact factor: 9.623

3.  Acute and chronic rejection: compartmentalization and kinetics of counterbalancing signals in cardiac transplants.

Authors:  A M K Kaul; S Goparaju; N Dvorina; S Iida; K S Keslar; C A de la Motte; A Valujskikh; R L Fairchild; W M Baldwin
Journal:  Am J Transplant       Date:  2015-01-12       Impact factor: 8.086

Review 4.  Hyaluronan in intestinal homeostasis and inflammation: implications for fibrosis.

Authors:  Carol A de la Motte
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-18       Impact factor: 4.052

Review 5.  Innate immunity and cardiac allograft rejection.

Authors:  Timothy M Millington; Joren C Madsen
Journal:  Kidney Int Suppl       Date:  2010-12       Impact factor: 10.545

6.  Burn-induced alterations in toll-like receptor-mediated responses by bronchoalveolar lavage cells.

Authors:  Richard F Oppeltz; Meenakshi Rani; Qiong Zhang; Martin G Schwacha
Journal:  Cytokine       Date:  2011-06-21       Impact factor: 3.861

7.  Suppression of PLCbeta2 by endotoxin plays a role in the adenosine A(2A) receptor-mediated switch of macrophages from an inflammatory to an angiogenic phenotype.

Authors:  Stan Grinberg; Gyorgy Hasko; Dianqing Wu; Samuel Joseph Leibovich
Journal:  Am J Pathol       Date:  2009-10-22       Impact factor: 4.307

Review 8.  Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses.

Authors:  Yoshinobu Maeda
Journal:  Int J Hematol       Date:  2013-08-28       Impact factor: 2.490

Review 9.  Role of TLRs and DAMPs in allograft inflammation and transplant outcomes.

Authors:  Faouzi Braza; Sophie Brouard; Steve Chadban; Daniel R Goldstein
Journal:  Nat Rev Nephrol       Date:  2016-03-30       Impact factor: 28.314

Review 10.  Innate immunity in heart transplantation.

Authors:  Timothy M Millington; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2009-10       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.